Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
PRIORITY PRESS - 9th Canadian Immunization Conference (CIC)
Public Health Programs: Burden of Disease, Cost-Effectiveness Key Factors in Funding Decisions
Quebec City, Quebec / December 5-8, 2010
Funding a public health program requires economic assessment of that program and attempts must be made to quantify both the burden of illness and the impact that illness has on quality of life. In the case of rotavirus (RV) infection, it is...
PRIORITY PRESS - 9th Canadian Immunization Conference (CIC)
Global Experience with Publicly-funded Rotavirus Vaccination Programs
Quebec City, Quebec / December 5-8, 2010
Rotavirus (RV) infection is associated with a substantial disease burden in Canadian children, as demonstrated by Dr. Nicole Le Saux, Children’s Hospital of Eastern Ontario, London. In a Toronto-based study carried out by Ford-Jones...
NEW FRONTIERS - 10th International Congress on Drug Therapy in HIV Infection
Renal Impairment and Other Complications in the Aging HIV Patient
Glasgow, UK / November 7-11, 2010
Morbidity related to accelerated aging in HIV infected individuals, a major focus of recent HIV/AIDS scientific programs, including the congress here in Glasgow, is now the single most important threat to patients with controlled HIV...
PRIORITY PRESS - 48th Annual Meeting of the Infectious Diseases Society of America
Closing in on Meningococcal Disease
Vancouver, British Columbia / October 21-24, 2010
Vancouver - Quadrivalent conjugated vaccines have proven highly effective against 4 serotypes of invasive meningococcal disease, including the virulent type C. Evidence indicates that booster vaccination in older individuals has the...
PRIORITY PRESS - 48th Annual Meeting of the Infectious Diseases Society of America
MRSA Nosocomial Pneumonia: Treatment and Resistance Update
Vancouver, British Columbia / October 21-24, 2010
Vancouver - As clinicians face multi-drug-resistant infections with a shrinking armamentarium, antimicrobial stewardship is of increasing importance. Making optimal antimicrobial choices at the most appropriate dose and duration is an...
PRIORITY PRESS - 48th Annual Meeting of the Infectious Diseases Society of America
Pneumococcal Vaccination: A North American Perspective
Vancouver, British Columbia / October 21-24, 2010
Universal vaccination programs for children using the 7-valent conjugated pneumococcal vaccine PCV7, initiated in British Columbia and Alberta in 2002 and in the rest of Canada in 2005, have resulted in a decline in disease burden and a...
NEW FRONTIERS - 1st International Workshop on HIV and Aging
Minimizing the Impact of HIV-driven Inflammation in an Aging Population
Baltimore, Maryland / October 4-5, 2010
Within the next 5 to 7 years, it is expected that the proportion of patients infected with HIV who are older than age 50 will surpass the proportion who are younger in several industrialized countries, including Canada and the US. This...
PRIORITY PRESS - 50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
Strategies on Reducing Morbidity and Mortality from Invasive Aspergillosis and Other Serious Fungal Infections
Boston, Massachusetts / September 12-15, 2010
Boston - Several strategies to reduce the rates of morbidity and mortality generated by invasive fungal infections over those currently achieved on guideline-directed care are being pursued simultaneously. Although targeted antifungal...
NEW FRONTIERS - XVIII International AIDS Conference (IAS)
Seeking Optimal First-line NRTI Backbones: Weighing the Evidence
Vienna, Austria / July 18-23, 2010
The most commonly used first-line nucleoside reverse transcriptase inhibitor (NRTI) combinations are abacavir/lamivudine (ABC/3TC) and tenofovir/emcitrabine (TDF/FTC). In most guidelines, both are considered appropriate for what is referred...